Navigation Links
Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 Presented at BMT Tandem Meetings
Date:2/19/2013

KVN identified through biopsy or autopsy, and suggested that BKVN may be an under-recognized cause of renal dysfunction in HSCT recipients.  Through Chimerix's expanded access study of CMX001, a recipient of HSCT was treated for BKVN with CMX001 100 mg twice weekly for six months.  After 10 months of therapy, the patient has maintained stable renal function without requiring hemodialysis.  This case report suggests that BKVN may be underdiagnosed in HSCT recipients and should be considered in patients with declining renal function.  Furthermore, these data support the potential role of CMX001 for the treatment of BKV infection and BKVN.

About Chimerix and CMX001

Chimerix is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need.  The Company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. 

Chimerix's lead product candidate, CMX001, is a broad spectrum, oral nucleotide analog lipid-conjugate that blocks replication of double-stranded DNA (dsDNA) viruses, including cytomegalovirus (CMV), adenovirus (AdV), BK virus and herpes simplex virus.  CMX001 has completed Phase 2 clinical development for the prevention of CMV in hematopoietic stem cell transplant (HSCT) recipients.  Chimerix is also conducting a Phase 2 study in HSCT recipients which is evaluating CMX001 as a preemptive therapy for AdV disease, an often-fatal infection which has no approved therapies.  Since 2009, Chimerix has made CMX001 available under expanded access regulations to over 80 transplant centers worldwide for the treatment of over 430 patients with life-threatening dsDNA viral infections.  Chimer
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dr. Diana Bianchi Presents Data Demonstrating Verinata Healths Proprietary Technology Detects Genetic Abnormalities In Twin Pregnancies
2. Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose
3. IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
4. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
5. Watson Applauds GPhA Study Demonstrating $1 Trillion in Prescription Drug Savings from Generic Medicines
6. Patient Safety, Science and Technology Summit Inspires Healthcare Industry Stakeholders to Action in Pursuit of 0 Preventable Patient Deaths by 2020
7. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
8. Zebra Technologies Connects the Dots Between the Patient Experience and Safety
9. Seven Denver Area Hospitals Join Colorado Health Information Exchange To Support Advancements In Health Care Quality & Safety
10. Cognizant Recognized as a Leader in Life Science Drug Safety Services in IDC MarketScape
11. Radiation Detection, Monitoring & Safety Market (Geiger Counter, Ionization Chamber, Scintillator, Terahertz detector, Dosimeter, Environment Monitor, Shield, Lead Apron, Eyewear & Glove) - Competitive Analysis & Global Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the "Physician Office Laboratory Markets, 3rd ... This report, Physician Office Laboratory Markets is ... the IVD industry. Physician office laboratories are diverse ... simply perform reimbursable, in-office pregnancy and glucose tests. ...
(Date:9/23/2014)... The Pennsylvania State Police will accept unwanted, expired ... of National Prescription Drug Take-Back Day. The service is ... Day is a national initiative, conducted in partnership with ... the public to dispose of expired, unused or unwanted ... From 10 a.m. to 2 p.m., unwanted ...
(Date:9/23/2014)... , Sept. 23, 2014 Research and ... "Biopharmaceutical and Vaccine Production Markets" report to their ... new therapies and vaccines - including products to treat ... still huge challenges during the final stages of clinical ... and how to risk production capital to upscale while ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3
... Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), ... and commercialization of its proprietary stent platform technology, ... summary of  three years collective data will be ... Transcatheter Cardiovascular Therapeutics (TCT) conference. The conference is ...
... Express Scripts, Inc., one of the largest ... Rexam as its 2011 Supplier of the Year. ... This award recognizes suppliers who have a ... continuous improvement in supplier relationship management, quality, service, ...
Cached Medicine Technology:InspireMD to Sponsor Satellite Symposium Breakfast Meeting Chaired by Dr. Gregg W. Stone November 9th at TCT 2011 2InspireMD to Sponsor Satellite Symposium Breakfast Meeting Chaired by Dr. Gregg W. Stone November 9th at TCT 2011 3InspireMD to Sponsor Satellite Symposium Breakfast Meeting Chaired by Dr. Gregg W. Stone November 9th at TCT 2011 4Rexam Chosen as Express Scripts' Supplier of the Year 2
(Date:9/23/2014)... 2014 The inaugural single day event ... Hotel New Otani Tokyo Gardens in Tokyo. Clinical data scientists ... and validation. , The second single day event in ... offices in Shanghai. The clinical data scientists attending this event ... figures and listings, which display data collected in clinical studies ...
(Date:9/23/2014)... "The primary purpose of the CALL LIGHT ... from Sacramento, Ca.. "Call lights are often found on the ... the IV pole out of the patient's reach. In order ... whenever they need it, I created this caddy." , She ... call device within easy reach. The accessory ensures that the ...
(Date:9/23/2014)... Downingtown, PA (PRWEB) September 24, 2014 ... traumatic stress disorder (PTSD) – and how it can ... 31, was deployed in Iraq in 2006. His platoon ... home in 2008, he was diagnosed with combat-related PTSD ... withdrawn, I was angry, and I had distanced myself ...
(Date:9/23/2014)... Karen Pallarito HealthDay Reporter ... if doctors and hospitals got paid for providing better ... better data for making informed health choices. A ... is headed. The report, from the IMS Institute for ... -- recent events expected to alter the delivery of health ...
(Date:9/23/2014)... 2014 What information do patients ... Quality Forum (NQF) released a report ( http://bit.ly/1DwekE9 ... an infographic ( http://bit.ly/1tX3lzA ) resulting from an ... how patients define affordability, and what information and ... best possible healthcare at the lowest possible cost. ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2
... , , , ROCHESTER, Minn., Sept. ... is the focus of a Perspectives article in ... 23, 2009, and in the print issue on Oct. 1, 2009. , ... , "We must hold physicians and other providers accountable for ...
... from the dried venom secreted by the skin glands of ... those normally administered, and may slow disease progression in some ... D. Anderson Cancer Center. The results from ... M. D. Anderson and Fudan University Cancer Hospital in Shanghai, ...
... The Weill Cornell Institute of Geriatric Psychiatry at ... the largest grant in its 20-year history. One ... million, five-year "Center Grant" from the National Institute ... investigators to advance their pioneering work in understanding ...
... registered in the past 30 years, cardiovascular disease (CVD) remains the ... In the EU, experts reveal that striking disparities still exist ... with regard to national prevention policies. In view of this, there ... tackle heart disease and stroke. The message coincides with ...
... ... ... -- Whether in a quest for beauty or out of necessity, millions of Americans will ... technologies, and research will be presented at Plastic Surgery 2009, the annual scientific meeting of ...
... flu not effective , THURSDAY, Sept. 24 (HealthDay News) ... give the wrong dose of Tamiflu to their children ... dosing instructions don,t always coincide with the measurement markings ... , The warning letter, penned by scientists from Northwestern ...
Cached Medicine News:Health News:Mayo Clinic Offers Perspective on Health Care Reform in New England Journal of Medicine 2Health News:M. D. Anderson examines use of toad venom in cancer treatment 2Health News:M. D. Anderson examines use of toad venom in cancer treatment 3Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 2Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 3Health News:Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant 4Health News:World Heart Day resonates with recent experts' findings on CVD and EU institutions' determination to promote heart health 2Health News:World Heart Day resonates with recent experts' findings on CVD and EU institutions' determination to promote heart health 3Health News:American Society Of Plastic Surgeons Hosts 78th Annual Meeting 2Health News:American Society Of Plastic Surgeons Hosts 78th Annual Meeting 3Health News:American Society Of Plastic Surgeons Hosts 78th Annual Meeting 4Health News:Letter Warns About Tricky Dosing With Liquid Tamiflu for Kids 2Health News:Letter Warns About Tricky Dosing With Liquid Tamiflu for Kids 3
... Bio-Rad isotopic anemia ... and minimal ,pipetting steps ... information about the processes ... and the benefit to ...
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
... The ImmunoDOT Autoimmunity Screening Panel ... test for screening and detection,of autoantibodies ... DNA, SS-A/SS-B, RNP/Sm) in serum, and ... diagnosis of systemic lupus erythematosus (SLE), ...
The MESACUP ANA Test Kit is a semi-quantitative enzyme-linked immunosorbent assay,(ELISA) for the detection of specific anti-nuclear antibodies in human serum as an aid in,the determination of autoim...
Medicine Products: